Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial-Reference-Cited by-同舟云学术

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Published:2022-11-10 Issue:12 Volume:7 Page:1996-2010
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Fong Youyi,McDermott Adrian B.^ORCID,Benkeser David^ORCID,Roels Sanne,Stieh Daniel J.,Vandebosch An,Le Gars Mathieu,Van Roey Griet A.,Houchens Christopher R.,Martins Karen,Jayashankar Lakshmi,Castellino Flora,Amoa-Awua Obrimpong,Basappa Manjula,Flach Britta,Lin Bob C.,Moore Christopher,Naisan Mursal,Naqvi Muhammed,Narpala Sandeep,O’Connell Sarah,Mueller Allen,Serebryannyy Leo,Castro Mike^ORCID,Wang Jennifer,Petropoulos Christos J.^ORCID,Luedtke Alex,Hyrien Ollivier,Lu Yiwen,Yu Chenchen,Borate Bhavesh,van der Laan Lars W. P.,Hejazi Nima S.^ORCID,Kenny Avi,Carone Marco^ORCID,Wolfe Daniel N.,Sadoff Jerald,Gray Glenda E.,Grinsztejn Beatriz,Goepfert Paul A.,Little Susan J.,Paiva de Sousa Leonardo^ORCID,Maboa Rebone,Randhawa April K.^ORCID,Andrasik Michele P.,Hendriks Jenny,Truyers Carla,Struyf Frank^ORCID,Schuitemaker Hanneke^ORCID,Douoguih Macaya^ORCID,Kublin James G.,Corey Lawrence^ORCID,Neuzil Kathleen M.^ORCID,Carpp Lindsay N.^ORCID,Follmann Dean^ORCID,Gilbert Peter B.^ORCID,Koup Richard A.,Donis Ruben O., , ,

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

https://www.nature.com/articles/s41564-022-01262-1.pdf

Reference46 articles.

1. Sadoff, J. et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N. Engl. J. Med. 384, 2187–2201 (2021).

2. Sadoff, J. et al. Final analysis of efficacy and safety of single-dose Ad26.COV2.S. N. Engl. J. Med. 386, 847–860 (2022).

3. Janssen COVID-19 Vaccine (US Food and Drug Administration, accessed 23 January 2022); https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine

4. COVID-19 Vaccines WHO EUL Issued (World Health Organization, accessed 24 January, 2022); https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued

5. European Commission Authorises Fourth Safe and Effective Vaccine Against COVID-19 (European Commission, accessed 24 January 2022); https://ec.europa.eu/commission/presscorner/detail/en/ip_21_1085

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up;Infection;2024-02-02

2. Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning;Annual Review of Pathology: Mechanisms of Disease;2024-01-24

3. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19;Frontiers in Public Health;2023-12-28

4. Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial;International Journal of Infectious Diseases;2023-12

5. Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time;Nature Communications;2023-11-02